| Serum HCG following ruptured ectopic pregnancy |
| Occupational exposure to Penthrox |
| VR headsets in gynaecological procedures |
| Pain management of endometriosis in pregnancy |
| Management of shoulder dystocia during water birth |
| The influence of low or high-risk settings on decision making and risk assessment |
| Arpepitant in pregnancy |
| Hypercalcemia in pregnancy |
| Infection risk of vaginal examinations in labour |
| Acute kidney injury in pregnancy |
| Normal serum creatinine levels in pregnancy |
| External cephalic version success with prior caesarean section |
| IVF success rates following caesarean section |
| Risk factors for endometrial cancer according to menopausal status (pre-vs postmenopause) |
| DCDA twins delivery beyond 37 weeks and risk of stillbirth |
| Women’s experiences of induction of labour |
| Storage of essential oils in maternity |
| HPV 16 transmission during vaginal delivery and labour |
| Dupilumab in pregnancy |
| Preterm birth and internal manoeuvres/instrumental delivery |
| Previous uterine myomectomy and mode of birth |
| Vaginismus in preganancy and birth |
| Use of clary sage and aromatherapy in labour and any risks of developing seizures |
| Use of Metformin for GDM and its association with fetal growth restriction |
| Rates of instrumental delivery associated with induction of labour |
| Ferric Derisomaltose vs. Ferric Carboxymaltose in Pregancy |
| The impact of childhood stress and trauma on pregnancy and maternal health |
| Eczema and MRSA |
| MRSA decolonisation strategies |
| Pleural endometriosis |
| Anti-NMDA encephalitis in pregnancy |
| Effectiveness/limitations of checklists for communication in antenatal appointments |
| Risk of ectopic pregnancy following caesarean birth |
| National rates of hypoxic-ischaemic encephalopathy |
| Hormonal contraception following ectopic pregnancy |
| Factor XI deficiency in pregnancy |
| Low PAPP-A and pregnancy outcomes |
| Elevated Uterine Artery Doppler and Risk of Stillbirth/Risks after 40 Weeks |
| Placentophagy |
| Anal fissures and vaginal birth risks |
| Anal diseases and vaginal birth |
| Episiotomy and risk of incontinence |
| Virtual reality headsets for the management of miscarriage and gynaecological procedures |
| Mirena coil (IUS) for the management of endometriosis |
| The effect of fetal movement resources in different languages on outcomes |
| Pruritis in pregnancy |
| Induction of labour success according to parity |
| Induction of labour in women aged >40 years at 40 weeks |
| Foley’s vs Cooks balloon catheters for induction of labour |
| Acute intermittent prophyria in pregnancy |
| Safety of misoprostol for intrauterine device insertion |
| Birth-associated injuries in spontaneous vaginal deliveries |
| Risk of recurrence of fourth-degree perineal tears |
| VTE risk in homozygous factor v Leiden |
| Effect of hands-on perineal care on obstetric and anal sphincter injury |
| Sudden infant death syndrome |
| Gestational age and risk of placental abruption |
| Proteinuria in pregnancy |
| Incidence of fetal skull fractures |
| Clinical utility of genetic and genomic testing in recurrent miscarriage |
| Cell-free DNA in testing the causes of miscarriage |
| JAK 1 and 2 inhibitors and breastfeeding |
| Psychological impact of access to genetic testing following miscarriage |
| Infectious complications following radiofrquency ablation for uterine fibroids |
| Management of copper IUD migration in pregnancy |
| Lasers for perineal trauma and gynaecological conditions |
| Genetic and genomic testing in stillbirth |
| IV tranexamic acid and renal cortical necrosis |
| Patient knowledge of IOL and assosciation with satisfaction |
| Statistics on instrumental delivery in primiparous women and failed instrumental delivery leading to emergency caesarean |
| Ulcerative colitis and mode of delivery |
| Neuromyelitis optica spectrum disorders and pregnancy |
| Subchorionic haematoma and risk of placental abruption |
| Congenital portal vein shunts and pregnancy |
| Hypermaganesaemia (effects on pregnancy/newborn/liver/nervous system) |
| BMI and IVF success rates |
| GLP-1 injections and weight loss in women |
| GLP-1 injections vs lifestyle changes in women aged 18-40 |
| OASI Care bundle effectiveness in practice |
| BMI and restrictive access to fertility treatment |
| Velamenous cord insertion and birth outcomes/mode of birth |
| Myopia and mode of delivery |
| Physiological fetal monitoring; fetal hypoxia |
| Effects of bariatric surgery on pregnancy and fertility |
| Transjugular intraheaptic portosystemic shunts for noncirrhotic portal hypertension in pregnancy |
| Antiphospholipid syndrome in pregnancy (including miscarriage management) |
| GLP1 agonist injection and efficacy of GnRH analogues |
| GLP-1 medications and conception rates/adverse pregnancy outcomes |
| BMI and spontaneous conception |
| Protein S deficiency and recurrent pregnancy loss |
| Psychological impact of delayed access to fertility treatment |
| Complementary therapies for induction of labour/inducing spontaneous labour |
| Vaginal delivery following induction of labour according to parirty |
| Neonatal or maternal outcomes in non-English speakers |
| Tydeman tube for the management of the impacted fetal head at caesarean section |
